Emerging Capitalization Trends in Embodied Intelligence: Shoucheng Holdings’ Strategic Robotics Investments

Introduction to Shoucheng Holdings’ Robotics Investment Landscape

As of mid-2026, Shoucheng Holdings (697.HK) is solidifying its position as a key player in the embodied intelligence sector by nurturing a robust pipeline of high-potential robotics companies. This strategic focus is evident in its portfolio, which includes notable ventures such as Galaxea, Galbot, and Unitree Robotics. These companies exemplify the transition of the robotics industry from private-market enthusiasm to public-market validation and capitalization.

High-Value Pre-IPO Ventures: Galaxea and Galbot

Galaxea and Galbot, both backed by Shoucheng Holdings through specialized industrial funds, have emerged as frontrunners in the high-valuation private robotics market. Galaxea recently secured nearly RMB 2 billion in a Series B+ funding round, pushing its valuation beyond RMB 20 billion. This follows a substantial RMB 1 billion Series B round earlier in the year, underscoring sustained investor confidence in its growth trajectory.

Similarly, Galbot completed a significant RMB 2.5 billion financing round in March 2026, attracting a diverse group of investors including state-level funds and market-driven institutions. Although neither company has yet filed for an IPO, their impressive fundraising achievements, valuation milestones, and ongoing equity restructuring signal strong market anticipation for their imminent public listings. These developments position Galaxea and Galbot as prime candidates for the next wave of IPOs following Unitree Robotics.

Unitree Robotics: Pioneering Public Market Entry

Unitree Robotics stands out as a trailblazer within Shoucheng Holdings’ robotics portfolio, having recently received approval from the China Securities Regulatory Commission (CSRC) to proceed with its initial public offering (IPO) on the STAR Market. This milestone marks Unitree as the first embodied intelligence company in China to approach public listing, setting a precedent for the sector.

The company aims to raise approximately RMB 4.2 billion by issuing over 40 million shares, representing at least 10% of its post-IPO equity, with an estimated market capitalization near RMB 42 billion. Unlike many early-stage robotics firms, Unitree Robotics has demonstrated profitability, reporting revenues of RMB 159 million in 2023, RMB 392 million in 2024, and a projected RMB 1.7 billion in 2025. Net profits, after excluding non-recurring items, have shown a positive trajectory from a slight loss in 2023 to an anticipated RMB 590 million in 2025. For the first half of 2026, revenue is expected to grow by 35.6% to 45.4%, reaching between RMB 1.05 billion and RMB 1.13 billion, with net profits forecasted between RMB 236 million and RMB 283 million despite increased R&D expenditures.

Commercialization and Scale: The Growth Engine Behind Unitree Robotics

Founder Wang Xingxing has publicly set ambitious shipment targets for 2026, aiming to deliver between 10,000 and 20,000 humanoid robots. With fresh capital from the IPO, Unitree Robotics plans to accelerate its research and development, expand manufacturing capabilities, and optimize its supply chain to reduce costs. This strategy is expected to create a virtuous cycle of increased production, cost efficiency, and market share expansion, reinforcing the company’s commercial viability and profitability.

For Shoucheng Holdings, this progression signifies a critical shift from early-stage technology validation to large-scale commercial success, enhancing the tangible value of its investments as they transition from private valuations to public market benchmarks.

Valuation Implications and Market Outlook

Based on the current IPO valuation, Shoucheng Holdings’ stake in Unitree Robotics is valued at approximately RMB 1.445 billion. Should Unitree’s market capitalization rise to RMB 50 billion or RMB 60 billion post-listing, the corresponding value of Shoucheng’s equity could increase to RMB 1.72 billion and RMB 2.06 billion, respectively. Market analysts view Unitree’s IPO approval as a pivotal moment that provides a transparent valuation reference for Shoucheng’s broader robotics portfolio, enhancing the visibility and credibility of its early-stage investments.

This public-market validation is expected to clarify the valuation framework for other portfolio companies like Galaxea and Galbot, facilitating their eventual capital-market entry and value realization.

Strategic Outlook: From Book Gains to Market Capitalization

Collectively, Galaxea, Galbot, and Unitree Robotics illustrate a well-defined capitalization trajectory within Shoucheng Holdings’ robotics fund. While Galaxea and Galbot remain in the high-valuation pre-IPO phase, Unitree Robotics is spearheading the transition to public market realization. This progression underscores the fund’s evolving investment thesis: moving from theoretical book gains to tangible capital-market validation and asset value realization.

As the embodied intelligence sector matures, shifting focus from prototype development to scalable commercialization, Shoucheng Holdings is poised to leverage its robotics investments as a significant driver of future growth. Beyond its established infrastructure asset management business, the company is cultivating a secondary growth engine through strategic investments in robotics and emerging technology assets.